Sign in
8-K

Current Report

LENZ Therapeutics, Inc. Filed Acc 0001628280-24-012633

Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure

  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 3.02 Unregistered sales of equity securities
  • Item 3.03 Material modification to rights of security holders
  • Item 4.01 Changes in the registrant's certifying accountant
  • Item 5.01 Changes in control of the registrant
  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 5.05 Amendment to or waiver of the code of ethics
  • Item 5.06 Change in shell company status
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading lenz-20240321.htm…